Docket Number:13A-920920
Inventor:Yu-Chan Chao, Yen-Yen Liu
IP Status:Issued TWI297040;US7,527,967B2
Abstract:
This invention relates to recombinant baculoviruses, virus-like particles, and polypeptide that contain a protein sequence of a heterologous virus, their compositions, and preparation, screening, delivery, detection, and treatment methods.
Fields of Application:
- For neutralization tests on the human sera to verify if it is infected by SARS CoV.
- For neutralization tests on the animal sera to verify if the oringinal is effective.
- For the screening and test of the drugs which is effective to cure SARS CoV.
- For the identification of SARS CoV target cells.
- For the delivery of genes into SARS CoV target cells.
- For the delivery of RNAi into SARS CoV target cells.
Advantages when compared to the existing technologies:
Now, for infection experiments, we have to use SARS CoV. This is very dangerous and only P3 laboratory can do it. Using virus like particle or baculovirus with spike, a conventional P2 laboratory can do very similar experiments. This is a safe, convenience, and economy technology.
Contact Person:Sue-Ming Chang / 886-2-2787-2600 / name4517@gate.sinica.edu.tw
